WETS
GOSS icon

Wealth Enhancement Trust Services’s Gossamer Bio GOSS Stock Holding History

Wealth Enhancement Trust Services’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$500 Buy
+3,039
New +$848 ﹤0.01% 1244

Other funds holding GOSS

CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $78.6B AUM 28.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MGW
MB Generational Wealth Spokane, Washington $204M AUM 25.77% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wealth Enhancement Trust Services's GOSS Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Gossamer Bio (GOSS) in Q2 2026: 3,039 shares worth $500. The stake represents ﹤0.01% of the portfolio and ranks #1244 among its holdings.

98 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Wealth Enhancement Trust Services held 3,039 shares of Gossamer Bio worth $500 as of Q2 2026.
  • Gossamer Bio was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1244 holding.
  • 98 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.